A detailed history of Rhumbline Advisers transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 42,949 shares of STXS stock, worth $97,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,949
Previous 48,251 10.99%
Holding current value
$97,064
Previous $87,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.76 - $2.35 $9,331 - $12,459
-5,302 Reduced 10.99%
42,949 $87,000
Q2 2024

Aug 01, 2024

BUY
$1.73 - $3.2 $72,279 - $133,696
41,780 Added 645.65%
48,251 $87,000
Q2 2023

Aug 08, 2023

BUY
$1.51 - $2.27 $9,771 - $14,689
6,471 New
6,471 $9,000
Q2 2022

Aug 11, 2022

SELL
$1.75 - $3.71 $73,319 - $155,437
-41,897 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$3.11 - $6.63 $8,975 - $19,134
2,886 Added 7.4%
41,897 $156,000
Q4 2021

Feb 10, 2022

SELL
$5.14 - $6.84 $4,600 - $6,121
-895 Reduced 2.24%
39,011 $242,000
Q3 2021

Nov 12, 2021

BUY
$5.34 - $9.87 $9,590 - $17,726
1,796 Added 4.71%
39,906 $215,000
Q2 2021

Aug 05, 2021

BUY
$6.41 - $10.17 $22,761 - $36,113
3,551 Added 10.28%
38,110 $367,000
Q1 2021

May 06, 2021

SELL
$4.43 - $7.95 $17,985 - $32,277
-4,060 Reduced 10.51%
34,559 $232,000
Q4 2020

Feb 10, 2021

BUY
$3.11 - $5.3 $16,949 - $28,885
5,450 Added 16.43%
38,619 $197,000
Q3 2020

Nov 12, 2020

SELL
$3.18 - $4.57 $24,358 - $35,006
-7,660 Reduced 18.76%
33,169 $119,000
Q2 2020

Aug 13, 2020

BUY
$2.71 - $5.47 $110,646 - $223,334
40,829 New
40,829 $182,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $169M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.